Context Delirium impedes communication and contributes to symptom distress in patients
with advanced cancer. There are few prospective data on the reversal of delirium in this …

Importance Antipsychotics are widely used for distressing symptoms of delirium, but efficacy
has not been established in placebo-controlled trials in palliative care. Objective To …

BACKGROUND Delirium is a common neuropsychiatric complication in patients with advanced
cancer. The Memorial Delirium Assessment Scale (MDAS) is a recently developed 10‐…

The comparative analysis of analgesic interventions for cancer pain is greatly compromised
by the lack of well-validated and clinically acceptable tools, which allow a composite …

BACKGROUND Current equianalgesic reference tables, based largely on single dose
studies, give dose ratios of 1:1 to 4:1 for oral morphine to oral methadone, which possibly are …

Delirium is a neurocognitive syndrome that commonly occurs in older populations and people
with cancer, particularly in those with advanced disease and in the last hours or days of life…

BACKGROUND Opioids have an essential role in the management of pain in cancer
patients, particularly those with advanced disease. Cognitive dysfunction is a recognized …

Background: Delirium is a common and distressing neurocognitive condition that frequently
affects patients in palliative care settings and is often underdiagnosed. Aim: Expanding on a …

Delirium is a frequent neurocognitive complication in patients with cancer, particularly in
patients with advanced-stage disease (in whom a combination of factors might trigger an …

Context In end-of-life care, delirium is often not recognized and poses unique management
challenges, especially in the case of refractory delirium in the terminal phase. Objectives To …